| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/09/2008 | CN101100467A Piperidinopyrazoles compound and its preparation method and application |
| 01/09/2008 | CN101100458A Bibenzimidazole derivative with PPARgamma exciting agent activity and application thereof |
| 01/09/2008 | CN101099860A Use of erythropoietin |
| 01/09/2008 | CN101099803A Pill-tablet for effective fat-reducing and treating three-high (hyperglycemia, hypertension and hyperlipemia) |
| 01/09/2008 | CN101099789A Hypoglycemic, antilipenic and treating hemopathy glutinous rehmannia extract and preparing method |
| 01/09/2008 | CN101099775A Cardiac and cerebral vascular disease treating medicine |
| 01/09/2008 | CN101099752A Method for extracting pollen essential from Chinese pine pollen |
| 01/09/2008 | CN101099741A Alprostadil and vitamin F millimicroball composite medicine and its preparation method |
| 01/09/2008 | CN101099573A Blood sugar reducing health fiber food |
| 01/09/2008 | CN101099566A Lactucin and its preparation method and application |
| 01/09/2008 | CN101099541A Low-salinity cultivating litopenaeus vannamei additive premixture |
| 01/09/2008 | CN101099540A Low-salinity cultivating litopenaeus vannamei environment-friendly type mixed feed |
| 01/09/2008 | CN100360658C Enteral microecological formulation and its preparation process |
| 01/09/2008 | CN100360628C Adhesive |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/09/2008 | CN100360548C Oligosaccharide derivative |
| 01/09/2008 | CN100360527C CB 1 receptor inverse agonists |
| 01/09/2008 | CN100360522C Novel compounds having selective inhibiting effect at GSK3 |
| 01/09/2008 | CN100360519C Benzothiepine ileal bile acid transport inhibitors |
| 01/09/2008 | CN100360505C Quinazoline derivatives as angiogenesis inhibitors |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/09/2008 | CN100360180C Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/09/2008 | CN100360164C Medicine for treating diabetes and its preparing process |
| 01/09/2008 | CN100360161C Chinese medicine for treating diabets and nephritis |
| 01/09/2008 | CN100360147C Medicinal composition, and its pharmaceutical use |
| 01/09/2008 | CN100360145C Fenugreek seed extract and its preparing process and application |
| 01/09/2008 | CN100360136C Unfermented gel fraction from psyllium seed husks |
| 01/09/2008 | CN100360134C Injection liquid containing alprostadic and its production process |
| 01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | US7317025 Non-peptidic NPY Y2 receptor inhibitors |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317012 Bicyclic heterocycles as cannabinoind-1 receptor modulators |
| 01/08/2008 | US7317011 Method of treating peripheral neuropathy |
| 01/08/2008 | US7316997 GH secretagogues and uses thereof |
| 01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/08/2008 | CA2394027C New derivatives of octahydro-2h-pyrido[1,2-a] pyrazine, their preparation process and pharmaceutical compositions that contain them |
| 01/08/2008 | CA2347750C Pharmaceutical composition containing decursin |
| 01/08/2008 | CA2334298C Neuropeptide y5 receptor antagonists |
| 01/08/2008 | CA2181164C Anti-gram-positive bacterial methods and materials |
| 01/08/2008 | CA2175603C Estrogen compositions and methods for neuroprotection |
| 01/07/2008 | CA2551578A1 Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis |
| 01/03/2008 | WO2008002824A1 Crystalline solvates and complexes of (is) -1, 5-anhydro-l-c- (3- ( (phenyl) methyl) phenyl) -d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes |
| 01/03/2008 | WO2008002655A2 Crystalline forms of atorvastatin |
| 01/03/2008 | WO2008002575A1 Melanin concentrating hormone antagonists |
| 01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 01/03/2008 | WO2008001931A2 Fused cyclic compounds |
| 01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |
| 01/03/2008 | WO2008001884A1 Antiarteriosclerosis agents |
| 01/03/2008 | WO2008001864A1 C-phenyl 1-thioglucitol compound |
| 01/03/2008 | WO2008001778A1 Genetically modified animal and use thereof |
| 01/03/2008 | WO2008001494A1 Pharmaceutical agent for prevention of fatigue and/or recovery from fatigue |
| 01/03/2008 | WO2008001160A1 Melanin concentrating hormone antagonists |
| 01/03/2008 | WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | WO2008000950A2 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 01/03/2008 | WO2008000692A2 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 01/03/2008 | WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
| 01/03/2008 | WO2008000549A1 Use of defibrotide for the inhibition of heparanase |
| 01/03/2008 | WO2008000484A1 Verfahren zur herstellung von pentamethylen-1,5-diisocyanat |
| 01/03/2008 | WO2008000447A1 New formulation for increasing bioavailability of neurturin |
| 01/03/2008 | WO2008000440A1 Use of a polyunsaturated fatty acid compound |
| 01/03/2008 | WO2008000166A1 Granule and preparation method thereof |
| 01/03/2008 | WO2008000070A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | WO2007127726A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/03/2008 | WO2007127502A3 Polymorphic form of { 2-methyl-4- [ 4-methyl-2- ( 4-triflu0r0methylphenyl) thiazol -5- ylmethylthiol phenoxy }-acetic acid |
| 01/03/2008 | WO2007124005A3 Methods for treating bone associated diseases by the use of methionine aminopeptidase-2 inhibitors |
| 01/03/2008 | WO2007118198A3 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/03/2008 | WO2007088421A3 A process for the removal of sterols and other compounds from glycerol oils |
| 01/03/2008 | US20080004338 Use of enantiomeric pure escitalopram |
| 01/03/2008 | US20080004336 Crystal structures of sglt2 inhibitors and processes for preparing same |
| 01/03/2008 | US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof |
| 01/03/2008 | US20080004293 Adenosine receptor antagonists and methods of making and using the same |
| 01/03/2008 | US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders |
| 01/03/2008 | US20080004257 Kinase inhibitors |
| 01/03/2008 | US20080004254 Compositions for weight management |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level |
| 01/03/2008 | US20080004218 Methods for enhanced epithelial permeation of y2 receptor-binding peptides for treating and preventing obesity |
| 01/03/2008 | US20080004217 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome (hadds) with or without lipodystrophy |
| 01/03/2008 | US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof |
| 01/03/2008 | US20080003312 Method of improving fat metabolism |
| 01/03/2008 | US20080003306 Compositions for weight management |
| 01/03/2008 | US20080003285 Immediate Release Pharmaceutical Tablets With Height Greater Than Width |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003279 Coenzyme Q10 Formulation and Process Methodology for Soft Gel Capsules Manufacturing |
| 01/03/2008 | US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof |
| 01/03/2008 | CA2787343A1 Compositions comprising modified lcat and uses thereof |
| 01/03/2008 | CA2659206A1 Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations |
| 01/03/2008 | CA2656277A1 Active agent formulations, methods of making, and methods of use |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2656003A1 Fused cyclic compounds |
| 01/03/2008 | CA2655937A1 C-phenyl 1-thioglucitol compound |
| 01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 01/03/2008 | CA2655881A1 Crystalline forms of atorvastatin |
| 01/03/2008 | CA2655522A1 Use of defibrotide for the inhibition of heparanase |
| 01/03/2008 | CA2655397A1 Pyrimidine and quinazoline derivatives |
| 01/03/2008 | CA2655233A1 Use of pkc inhibitors in diabetic complications |